PTEN’s regulation of VEGF and VEGFR1 expression and its clinical significance in myeloid leukemia

被引：0
作者：
Cheng Zhiyong
Liang Wentong
Yang Xiaoyang
Pan Ling
机构：
[1] The First Hospital of Baoding,Department of Hematology
[2] Central South University,Department of Hematology, Affiliated Haikou Hospital
[3] Sichuan University,Department of Hematology, West China Hospital
来源：
Medical Oncology | 2012年 / 29卷
关键词：
PTEN; VEGF; VEGFR1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Phosphatase and tensin homolog (PTEN) acts as a novel tumor suppressor gene. PTEN protein plays an important role in regulating proliferation, apoptosis, invasion, and migration of many cancer cells. PTEN also modulates angiogenesis mediated by vascular endothelial growth factor (VEGF) via down-regulating PI3K/Akt pathway in many solid tumors. However, the effects of PTEN on VEGF and VEGFR1 (FLT1)-mediated angiogenesis, migration, invasion of leukemia cells, and its clinical significance are still unknown in myeloid leukemia. Therefore, we investigated the effect of PTEN on PI3K/Akt and VEGF/FLT1 pathways by transfecting wild-type PTEN gene to induce high expression of wild-type PTEN gene and protein in chronic myelogenous leukemia cell line K562 cells. We also observed the correlation between the expression levels of PTEN and VEGF/FLT1 and its clinical significance in myeloid leukemia patients. We found that the expression reconstitution of wild-type PTEN had significant effect on inhibiting proliferation, migration, and invasion abilities of K562 cells via down-regulation of Akt phosphorylation and inhibition of VEGF/FLT1 expression. In myeloid leukemia patients, a negative correlation was found between the expression level of PTEN mRNA and that of VEGF and FLT1 mRNA. Down-regulation of PTEN expression accompanied by up-regulation of VEGF and FLT1 mRNA indicated a higher tendency of extramedullary disease in acute myeloid leukemia patients. In conclusion, PTEN could modulate the function of VEGF/VEGFR signaling pathway down-regulation of Akt phosphorylation and that PTEN would be a candidate target to be addressed for inhibiting angiogenesis along with the treatment of myeloid leukemia.
引用
收藏
页码：1084 / 1092
页数：8
相关论文
共 63 条
[1]  
Jiang BH(2008)AKT signaling in regulating angiogenesis Curr Cancer Drug Targets 8 19-26
[2]  
Liu LZ(2000)Phosphatidylinositol 3- kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells Proc Natl Acad Sci USA 97 1749-1753
[3]  
Jiang BH(1997)PTEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase Proc Natl Acad Sci USA 94 9052-9057
[4]  
Zheng JZ(1998)Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN Science 280 1614-1617
[5]  
Aoki M(2001)PTEN controls tumor-induced angiogenesis Proc Natl Acad Sci USA 98 4622-4627
[6]  
Myers MP(2005)The PTEN/PI3 K pathway governs normal vascular development and tumor angiogenesis Genes Dev 119 2054-2065
[7]  
Stolarov JP(2009)Quantification of VEGF isoforms and VEGFR transcripts by qRT-PCR and their significance in acute myeloid leukemia Int J Biol Markers 24 22-31
[8]  
Eng C(1998)Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3’-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation J Biol Chem 273 30336-30343
[9]  
Tamura M(2008)PI3K/PTEN signaling in tumorigenesis and angiogenesis Biochim Biophys Acta 1784 150-158
[10]  
Gu J(2003)Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells Diabetes 52 2959-2968
1234567